image
Summit Therapeutics Inc. SMMT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 18.31
-5.86 %
$ 13.5 B
Market Cap
-79.61
P/E
BALANCE SHEET
203 M ASSETS
-69.44%
Growth Rates
1Year -69.44%
3Years 25.57%
5Years 20.96%
7Years 23.25%
10Years 33.92%
125 M LIABILITIES
-76.70%
Growth Rates
1Year -76.70%
3Years 75.82%
5Years 40.85%
7Years 13.59%
10Years 44.84%
77.7 M EQUITY
-38.66%
Growth Rates
1Year -38.66%
3Years -0.74%
5Years 6.84%
7Years 53.19%
10Years 25.75%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Summit Therapeutics Inc.
image
Current Assets 190 M
Cash & Short-Term Investments 186 M
Receivables 848 K
Other Current Assets 2.62 M
Non-Current Assets 13.2 M
Long-Term Investments 0
PP&E 6.06 M
Other Non-Current Assets 7.17 M
Current Liabilities 20.4 M
Accounts Payable 2.67 M
Short-Term Debt 2.81 M
Other Current Liabilities 14.9 M
Non-Current Liabilities 105 M
Long-Term Debt 103 M
Other Non-Current Liabilities 1.56 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Jan-2019 Jan-2018 Jan-2017 Jan-2016 Jan-2015 Jan-2014 Jan-2013 Jan-2012 Jan-2011 Jan-2010 Jan-2009 Jan-2008 Jan-2007 Jan-2006 Jan-2005 Jan-2004
ASSETS
Cash & Cash Equivalents 71.4 348.6 71.8 66.4 64.1 35.2 28.5 35.1 23.2 17.0 3.3 5.3 3.3 5.1 9.7 3.9 20.1 35.9 22.6 26.7 0.1
Short Term Investments 114.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.7 0 0
Receivables 0.8 0.3 1.5 10.2 6.8 0 11.1 0 2.3 0 0 0 0 0 0 1.0 1.5 1.3 0 0 0
Inventory 0 301.5 7.2 (11.7) 2 0 0 0.1 0.6 4.2 1 0 0 0 0 0.6 0.7 0.4 48.2 K 0 0
Other Current Assets 2.6 302.0 8.4 11.1 15.4 26.0 22.3 5.4 6.5 5.3 1.8 1.3 0.9 0.8 0.9 2.3 3.1 2.2 1.0 0.2 0
Total Current Assets 189.7 656.7 97.3 66.4 79.7 61.3 50.8 41.7 29.7 22.9 5.1 6.6 4.2 5.9 10.6 7.8 25.3 38.4 23.6 26.8 0.1
PP&E 6.1 5.1 3.5 1.3 1.5 0.8 1.1 0.1 0.1 82.9 K 70.9 K 36.3 K 0.2 0.4 0.5 5.4 8.5 5.1 2.3 1.88 K 0
Intangible Assets 0 0 10.4 11.5 9.9 13.9 20.9 4.3 4.9 5.2 5.8 0.3 1.7 1.7 7.2 6.9 16.2 2.9 50 K 37.7 K 0
Goodwill 1.9 1.8 2.0 2.0 2.4 2.4 3.5 0.8 0.9 1.0 0.7 0 0 0 0 0 19.4 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 1.47 0 0.000001 0.894 0.000001 1.97 0 0
Other Long Term Assets 5.3 0.6 0.2 21.3 4.2 1 0 0 0 1 0 0 (3.3) (5.1) (9.7) (3.9) (20.1) (35.9) (1.9) (26.7) 0
Other Assets 0 0 0 0 0 1 0 1 1 1 1 1 1 1 1 0 0 1 0 1 0
Total Assets 202.9 664.2 113.4 102.5 96.9 78.4 76.4 47.0 35.7 29.2 10.9 6.9 6.1 8.1 18.4 20.1 69.4 46.4 25.9 26.9 0.1
LIABILITIES
Accounts Payable 2.7 0.4 4.4 6.1 3.4 5.8 12.5 1.1 1.0 5.4 0.6 0.4 0.6 0.5 0.2 1.0 3.6 2.3 0.9 33.9 K 0
Short Term Debt 2.8 21.5 1.1 0.4 1.2 0 0 0 0 0 0 0 0 0 0 0.2 0.4 0.1 0.1 0 0
Other Current Liabilities 14.9 17.0 12.5 5.0 7.5 10.8 19.8 9.6 3.4 0.2 2.4 1.0 1.4 1.4 1.5 1.5 2.8 0.5 0.3 0.3 3.65 K
Total Current Liabilities 20.4 38.8 25.6 19.9 12.7 16.9 26.8 13.6 4.6 5.7 3.1 2.4 2.0 1.9 1.8 2.7 6.6 2.8 1.3 0.4 3.65 K
Long Term Debt 103.3 497.3 1.3 75 K 0.3 0 (16.2) 0 0 0 0 0 0 0 0 1.7 2.4 1.2 1.2 0 0
Deferred Tax Income 0 0 0 0 2.1 2.2 3.4 0.7 0.9 1.0 0 0 0 0 1.5 1.5 3.7 0 0 0 0
Other Liabilities 1.6 1.4 3.2 2.5 2.8 3.3 5.7 39.9 K 7.3 0 0 0 0.3 0.3 1.9 1.9 2.3 2.3 0 0 0
Total Liabilities 125.3 537.5 30.1 23.0 18.4 22.6 62.4 51.3 5.6 6.7 3.1 2.4 2.3 2.2 5.2 7.8 15.3 6.3 2.5 0.4 3.65 K
EQUITY
Common Stock 7.0 2.1 1.0 0.8 4.4 2.1 1.0 0.8 0.9 0.6 16.6 13.9 11.2 11.0 11.0 8.1 12.7 7.3 5.6 5.9 1.82 K
Retained Earnings (993.3) (378.3) (299.5) (214.7) (125.3) (99.8) (114.5) (92.2) (67.4) (45.6) (74.5) (61.7) (54.7) (50.9) (43.9) (52.8) (28.3) (8.1) (2.0) 86.6 K 40.1 K
Other Accumulative Comprehensive Income/Loss (2.4) (1.9) (2.2) (3.8) 28.3 0 0 25.7 27.3 (3.2) (3.2) (3.1) (1.7) (1.6) (5.2) (3.2) (2.5) (0.9) (0.2) 1.88 K 0
Total Equity 77.7 126.7 83.3 79.5 78.5 55.8 14.0 (4.4) 30.1 22.5 7.9 4.5 3.8 5.8 13.2 12.3 54.1 40.1 23.4 26.5 0.1
Total Liabilities and Equity 202.9 664.2 113.4 102.5 96.9 78.4 76.4 47.0 35.7 29.2 10.9 6.9 6.1 8.1 18.4 20.1 69.4 46.4 25.9 26.9 0.1
SHARES OUTSTANDING
Common Shares Outstanding 619.6 193.3 92.2 69.5 164.1 86.1 65.0 61.5 59.1 39.6 4.8 15.8 177.9 166.3 67.0 53.4 47.9 36.4 31.3 23.5 19.0